New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 3, 2012
12:47 EDTIPSEYIpsen, Galderma increase collaboration for Dysport in new territories
Ipsen and Galderma announced that their collaboration for the promotion and distribution of Dysport, Ipsenís botulinum toxin type A in aesthetic indications, has been extended. Both companies renewed their collaboration in Brazil and Argentina and extended their partnership to Australia where Galderma has the exclusive promotion and distribution rights for Ipsenís Dysport in glabellar lines indication. Both companies also entered into a co-promotion agreement in South Korea where Galderma and Ipsen will co-promote Dysport and Restylane.
News For IPSEY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2015
09:06 EDTIPSEYIpsen says Lancet Neurology publishes Dysport Phase III trial results
Subscribe for More Information
05:24 EDTIPSEYIpsen announces publication of Dysport Phase III results in Lancet Neurology
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use